sb 202190 has been researched along with Polyploid in 1 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conde, I | 1 |
| Pabón, D | 1 |
| Jayo, A | 1 |
| Lastres, P | 1 |
| González-Manchón, C | 1 |
1 other study available for sb 202190 and Polyploid
| Article | Year |
|---|---|
Involvement of ERK1/2, p38 and PI3K in megakaryocytic differentiation of K562 cells.
Topics: Cell Differentiation; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Flow Cytometry; | 2010 |